Skip to main content
. 2015 May 20;9:889–901. doi: 10.2147/OPTH.S80972

Table 14.

Posterior uveitis diagnoses

UVA
n=62 (%)
Duke5
n=93*
MEEI3
n=240*
USC26
n=230*
UCLA**9
n=31*
KY1
n=414*
IA**10
n=52*
REH**8
n=3,301*
Toxoplasma 11 (17.7) 42.0 24.6 9.0 35.5 7.7 65.0 6.9
Multifocal choroiditis 9 (14.5) 18.0 9.7 10.1 0.8
Undifferentiated 9 (14.5) 9 13.3 15.0 16.2 19.3 48.0
Acute retinal necrosis 4 (6.5) 9 5.5 2.7 0.2
Birdshot 7 (11.3) 3 7.9 3.0 6.5 3.4 1.09
MEWDS 3 (4.8) 1.25 1.2 0.4
APMPPE 3 (4.8) 2 2.0
Serpiginous 3 (4.8) 1.6 5.0 3.2 3.9 0.3
Sarcoidosis 2 (3.2) 7.5 3.9 2.2 4.0 2.9
CMV 2 (3.2) 11.6 7.0 31.2 0.7
Syphilis 1 (1.6) 2.0 4.0
Polyarteritis nodosa 1 (1.6) 0.83
Eales disease 1 (1.6)
Others 2 (3.2)

Notes: Others included: IRVAN (2).

*

All values given as percentage only.

**

UCLA, IA, and REH values extrapolated from given data.

Abbreviations: APMPPE, acute posterior multifocal placoid pigment epitheliopathy; CMV, cytomegalovirus; Duke, Duke University; IA, University of Iowa; IRVAN, idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis; KY, University of Louisville, Kentucky; MEEI, Massachusetts Eye and Ear Infirmary; MEWDS, multiple evanescent white dot syndrome; REH, Royal Eye Hospital, Manchester, UK; USC, University of Southern California; UCLA, University of California at Los Angeles; UVA, University of Virginia.